Skip to main content

Seattle Genetics Inc (NASDAQ: SGEN) Investor Securities Class Action Lawsuit 01/10/2017

  • If you purchased shares of Seattle Genetics Inc (NASDAQ: SGEN), you may have certain options. Please contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Lawsuit Overview

May 24, 2018 - The court granted defendants' motion to dismiss. January 5, 2018 - A motion to dismiss the second amended consolidated complaint was filed. November 17, 2017 - A second amended consolidated complaint was filed. October 18, 2017 - The court granted the defendants' motion to dismiss. The plaintiffs were given leave to amend the complaint. July 28, 2017 - A motion to dismi...



You must register (for free) or login to view the entire case.